Journal article
MAOIs in Adolescent Major Depression Unresponsive to Tricyclic Antidepressants
Journal of the American Academy of Child and Adolescent Psychiatry, v 27(6), pp 755-758
01 Nov 1988
PMID: 3198564
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Many adolescents with major depressive disorder have at most partial response to standard tricyclic antidepressants despite appropriate dosage and adequate length of treatment. This paper reports a series of 23 such adolescents who were treated with monoamine oxidase inhibitors (MAOIs). Seventy-four percent of this group achieved good or fair antidepressant response, 57% had both good or fair response and continued dietary compliance. There were few serious side effects. Special attention must be paid to subject selection for treatment with MAOIs because of the risk of impulsive or accidental dietary transgression. This retrospective chart review strongly suggests the need for controlled studies of MAOI treatment in adolescents with tricyclic antidepressant refractory major depression.
Metrics
Details
- Title
- MAOIs in Adolescent Major Depression Unresponsive to Tricyclic Antidepressants
- Creators
- NEAL D. RyanJOAQUIM PUIG-ANTICHHARRIS RabinovichJANE FriedPAUL AmbrosiniVIVECA MeyerDEBORAH TorresSUSAN DachilleDEBORAH Mazzie
- Publication Details
- Journal of the American Academy of Child and Adolescent Psychiatry, v 27(6), pp 755-758
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Psychiatry; [Retired Faculty]
- Web of Science ID
- WOS:A1988Q943900016
- Scopus ID
- 2-s2.0-0024217437
- Other Identifier
- 991021895632204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pediatrics
- Psychiatry
- Psychology, Developmental